Skip to Main Navigation Skip to Page Content

Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Cytembena: Target Organs and Levels of Evidence for TR-207

Carcinogenesis Bioassay of Cytembena (CASRN 21739-91-3)

Chemical (Study Title) CASRN	Peer Review Date	Route/Exposure Levels	Study Laboratory
Cytembena 21739-91-3	06/27/1980	Intraperitoneal Injection R: 0,7,14, M: 0,12,24 MG/KG/50 PER GROUP	Southern Research Institute

Levels of Evidence

Male Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Mesothelium (Abdominal Cavity/Tunica Vaginalis): MESOTHELIOMA 0/50 37/50 36/50

Female Rats: Positive

Type	Organ/Tissue (Lesion)
Neoplastic Lesions	Mammary Gland: FIBROADENOMA 13/49 22/50 36/50

Cytembena: Target Organs and Levels of Evidence for TR-207

Carcinogenesis Bioassay of Cytembena (CASRN 21739-91-3)

Levels of Evidence

Male Rats: Positive

Female Rats: Positive

Male Mice: Negative

Female Mice: Negative